Interestingly, we have shown that when CD200-Fc is combined with a different class of antibiotic, co-trimoxazole, we do see a consistent reduction in liver infection at day 3 post-infection, which is statistically significant (see Fig. S1 in the supplemental material). This evidence concerns the gene CD200 and infection.